Tuberculosis
Researchers from the Tongji University School of Medicine in Shanghai, China, have made a groundbreaking discovery on how Mycobacterium tuberculosis (Mtb), the bacteria responsible for tuberculosis, manipulates host responses to promote its intracellular survival. According to their study, published in Nature Microbiology, Mtb uses a metabolite called linoleic acid to
Tuberculosis
A study published in the journal Redox Report presents fresh data on the treatment of Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB). The research highlights the potential of Host-directed therapy (HDT) in shortening treatment duration and limiting resistance to drugs. The study focuses on the flavonoid Scutellarin (SCU)
Tuberculosis
Researchers have identified four distinct adherence patterns among patients treated for rifampicin- or multidrug-resistant tuberculosis (RR/MDR-TB), contradicting the traditional notion that sustained high adherence is necessary for treatment success. By analyzing data from the endTB observational study, a joint latent class mixed model was applied to classify adherence trajectories
Tuberculosis
Researchers from the Arabian Gulf University have published a study on the global research trends in BPaL and BPaLM regimens for drug-resistant tuberculosis, revealing the introduction of these regimens has revolutionized treatment, offering superior efficacy and tolerability. The study analyzed Scopus-indexed publications, identifying 1,081 authors and 120 studies meeting
Tuberculosis
A study published in BMC Microbiology has presented promising findings on a novel colorimetric test for diagnosing tuberculosis (TB) drug susceptibility in resource-constrained settings. The research, conducted by a team led by Binyam Mebrat from the Armauer Hansen Research Institute in Addis Ababa, Ethiopia, evaluated the performance of the phenotypic
Tuberculosis
Researchers at the Faculty of Medicine University of Indonesia have published a new study investigating the effectiveness of telemedicine-based directly observed therapy (DOTS) on treatment compliance in patients with tuberculosis. The study, which analyzed six systematic reviews, found that telemedicine-based DOTS yielded favorable effects in improving adherence, treatment completion, and
Tuberculosis
Researchers from Keele University have shed light on the critical issue of non-adherence to tuberculosis (TB) treatment among Afghan refugees and Pakistani nationals living in Pakistan. The study, published in the BMJ Open, identified several personal, sociocultural, and treatment-related barriers contributing to lower treatment adherence. These barriers include lack of
Tuberculosis
A new report from Vietnam highlights the critical importance of early diagnosis of pulmonary artery pseudoaneurysm (PAP) in patients presenting with hemoptysis, especially those with a history of pulmonary tuberculosis. According to research published in Radiology Case Reports, a 57-year-old male with poorly controlled type 2 diabetes mellitus and hypertension
Tuberculosis
A rare case of bilateral multiple lower limb tuberculous aneurysms was diagnosed in a pregnant woman due to drug-induced liver injury resulting from tuberculosis (TB) treatment, according to a new study published in Jurnal Respirasi. The patient, a 27-year-old woman at 14-15 weeks of gestation, was found to have painless
Tuberculosis
According to a new report published in the journal PLOS Neglected Tropical Diseases, researchers have identified key barriers to effective rabies control in rural Uganda. The study found that only an estimated 10% of dogs in Uganda are vaccinated against rabies, resulting in about 59,000 human deaths annually. The
Tuberculosis
A new study has reported a case of Achromobacter spp. infection in an immunocompetent woman with a history of pulmonary tuberculosis (PTB) and COVID-19. The study suggests that the high burden of TB and COVID-19 in Cameroon may lead to underreported pulmonary bacterial and fungal superinfections. Key Takeaways: * A 63-year-old
Tuberculosis
A recent case report published in the Infection and Drug Resistance journal has highlighted a potential and rare side effect of the medication dupilumab, a fully human monoclonal antibody used to treat moderate-to-severe atopic dermatitis. According to the research, a 71-year-old man developed pulmonary tuberculosis (PTB) and extrapulmonary tuberculosis (EPTB)
